TSHA - Trinity Capital provides $40M term loan to Taysha Gene Therapies
2023-12-19 07:43:02 ET
More on Trinity Capital, Taysha Gene Therapies, etc.
- Trinity Capital: Top 4 High Dividend Stock, 15% Yield, Record Q3 Earnings
- Taysha Gene Therapies, Inc. (TSHA) Q3 2023 Earnings Call Transcript
- Trinity Capital: 13.6% Yield, Healthy Financials, Still A Buy?
- Trinity Capital provides $45 million growth capital to Neurolens
- Trinity Capital Q3 2023 Earnings Preview
For further details see:
Trinity Capital provides $40M term loan to Taysha Gene Therapies